Sheets Smith Wealth Management Grows Stock Position in Stryker Corporation $SYK

Sheets Smith Wealth Management boosted its position in shares of Stryker Corporation (NYSE:SYK) by 50.6% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,533 shares of the medical technology company’s stock after buying an additional 1,523 shares during the quarter. Sheets Smith Wealth Management’s holdings in Stryker were worth $1,427,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Gables Capital Management Inc. purchased a new stake in Stryker in the 2nd quarter worth about $25,000. Kilter Group LLC bought a new position in shares of Stryker during the second quarter valued at approximately $25,000. Godfrey Financial Associates Inc. bought a new position in shares of Stryker during the fourth quarter valued at approximately $26,000. Sankala Group LLC purchased a new stake in shares of Stryker in the fourth quarter worth approximately $26,000. Finally, Compass Financial Management LLC bought a new stake in shares of Stryker during the 2nd quarter worth approximately $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Buying and Selling at Stryker

In other news, insider Debra King sold 826 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total value of $277,783.80. Following the completion of the sale, the insider owned 6,210 shares in the company, valued at approximately $2,088,423. The trade was a 11.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Dylan Bram Crotty sold 441 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $328.61, for a total transaction of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares of the company’s stock, valued at $2,005,178.22. The trade was a 6.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 351,267 shares of company stock valued at $118,197,701. Company insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have commented on SYK shares. Wolfe Research downgraded Stryker from an “outperform” rating to a “peer perform” rating in a research report on Thursday, August 13th. Raymond James Financial set a $370.00 target price on Stryker in a research report on Friday, July 31st. Argus set a $370.00 price target on shares of Stryker in a report on Thursday, July 9th. Citigroup reaffirmed a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Finally, Leerink Partners decreased their price objective on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $386.28.

Stryker Trading Up 2.9%

Shares of NYSE SYK opened at $331.32 on Friday. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The firm has a market cap of $127.08 billion, a PE ratio of 34.33, a price-to-earnings-growth ratio of 2.11 and a beta of 0.76. The business has a fifty day simple moving average of $329.10 and a two-hundred day simple moving average of $331.47. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter last year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts expect that Stryker Corporation will post 15.02 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.